These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 27252381)

  • 1. Phosphorylation Interferes with Maturation of Amyloid-β Fibrillar Structure in the N Terminus.
    Rezaei-Ghaleh N; Kumar S; Walter J; Zweckstetter M
    J Biol Chem; 2016 Jul; 291(31):16059-67. PubMed ID: 27252381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Turn plasticity distinguishes different modes of amyloid-β aggregation.
    Rezaei-Ghaleh N; Amininasab M; Giller K; Kumar S; Stündl A; Schneider A; Becker S; Walter J; Zweckstetter M
    J Am Chem Soc; 2014 Apr; 136(13):4913-9. PubMed ID: 24617810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulsed hydrogen-deuterium exchange mass spectrometry probes conformational changes in amyloid beta (Aβ) peptide aggregation.
    Zhang Y; Rempel DL; Zhang J; Sharma AK; Mirica LM; Gross ML
    Proc Natl Acad Sci U S A; 2013 Sep; 110(36):14604-9. PubMed ID: 23959898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemical modifications of amyloid-β(1-42) have a significant impact on the repertoire of brain amyloid-β(1-42) binding proteins.
    Medvedev AE; Buneeva OA; Kopylov AT; Mitkevich VA; Kozin SA; Zgoda VG; Makarov AA
    Biochimie; 2016; 128-129():55-8. PubMed ID: 27400251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular structure of an N-terminal phosphorylated β-amyloid fibril.
    Hu ZW; Vugmeyster L; Au DF; Ostrovsky D; Sun Y; Qiang W
    Proc Natl Acad Sci U S A; 2019 Jun; 116(23):11253-11258. PubMed ID: 31097588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural studies of amyloid-β peptides: Unlocking the mechanism of aggregation and the associated toxicity.
    Aleksis R; Oleskovs F; Jaudzems K; Pahnke J; Biverstål H
    Biochimie; 2017 Sep; 140():176-192. PubMed ID: 28751216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphorylation of the amyloid β-peptide at Ser26 stabilizes oligomeric assembly and increases neurotoxicity.
    Kumar S; Wirths O; Stüber K; Wunderlich P; Koch P; Theil S; Rezaei-Ghaleh N; Zweckstetter M; Bayer TA; Brüstle O; Thal DR; Walter J
    Acta Neuropathol; 2016 Apr; 131(4):525-37. PubMed ID: 26898910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphorylation modifies the molecular stability of β-amyloid deposits.
    Rezaei-Ghaleh N; Amininasab M; Kumar S; Walter J; Zweckstetter M
    Nat Commun; 2016 Apr; 7():11359. PubMed ID: 27072999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The solvent protection of alzheimer amyloid-beta-(1-42) fibrils as determined by solution NMR spectroscopy.
    Olofsson A; Sauer-Eriksson AE; Ohman A
    J Biol Chem; 2006 Jan; 281(1):477-83. PubMed ID: 16215229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorylation at Ser
    Hu ZW; Ma MR; Chen YX; Zhao YF; Qiang W; Li YM
    J Biol Chem; 2017 Feb; 292(7):2611-2623. PubMed ID: 28031462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined High-Pressure and Multiquantum NMR and Molecular Simulation Propose a Role for N-Terminal Salt Bridges in Amyloid-Beta.
    Vemulapalli SPB; Becker S; Griesinger C; Rezaei-Ghaleh N
    J Phys Chem Lett; 2021 Oct; 12(40):9933-9939. PubMed ID: 34617758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular prion protein targets amyloid-β fibril ends via its C-terminal domain to prevent elongation.
    Bove-Fenderson E; Urano R; Straub JE; Harris DA
    J Biol Chem; 2017 Oct; 292(41):16858-16871. PubMed ID: 28842494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropathology and biochemistry of Aβ and its aggregates in Alzheimer's disease.
    Thal DR; Walter J; Saido TC; Fändrich M
    Acta Neuropathol; 2015 Feb; 129(2):167-82. PubMed ID: 25534025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluorescence-Labeled Amyloid Beta Monomer: A Molecular Dynamical Study.
    Gera J; Paragi G
    Molecules; 2020 Aug; 25(15):. PubMed ID: 32752239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Template induced conformational change of amyloid-β monomer.
    Xi W; Li W; Wang W
    J Phys Chem B; 2012 Jun; 116(25):7398-405. PubMed ID: 22670893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quenched hydrogen-deuterium exchange NMR of a disease-relevant Aβ(1-42) amyloid polymorph.
    Wälti MA; Orts J; Riek R
    PLoS One; 2017; 12(3):e0172862. PubMed ID: 28319116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Familial Alzheimer's disease mutations at position 22 of the amyloid β-peptide sequence differentially affect synaptic loss, tau phosphorylation and neuronal cell death in an ex vivo system.
    Tackenberg C; Kulic L; Nitsch RM
    PLoS One; 2020; 15(9):e0239584. PubMed ID: 32966331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual effects of familial Alzheimer's disease mutations (D7H, D7N, and H6R) on amyloid β peptide: correlation dynamics and zinc binding.
    Xu L; Chen Y; Wang X
    Proteins; 2014 Dec; 82(12):3286-97. PubMed ID: 25137638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alternate aggregation pathways of the Alzheimer beta-amyloid peptide: Abeta association kinetics at endosomal pH.
    Gorman PM; Yip CM; Fraser PE; Chakrabartty A
    J Mol Biol; 2003 Jan; 325(4):743-57. PubMed ID: 12507477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amide solvent protection analysis demonstrates that amyloid-beta(1-40) and amyloid-beta(1-42) form different fibrillar structures under identical conditions.
    Olofsson A; Lindhagen-Persson M; Sauer-Eriksson AE; Ohman A
    Biochem J; 2007 May; 404(1):63-70. PubMed ID: 17280549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.